News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Elvina Almuradova: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
Elvina Almuradova and Komal Jhaveri
Apr 9, 2025, 08:51

Elvina Almuradova: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Elvina Almuradova, Ambassador at European School of Oncology, shared an article Komal Jhaveri and her colleagues authored on X:

“New in NEJM!!!

Imlunestrant shows promise in ER+/HER2- advanced breast cancer with ESR1 mutations – PFS 5.5 vs 3.8 months vs standard therapy. Adding Abemaciclib boosts PFS to 9.4 months.”

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Authors: Komal L. Jhaveri et al.

Elvina Almuradova

Imlunestrant and Abemaciclib: A Study in Advanced Breast Cancer
André Mattar Antonio Llombart-Cussac Breast Cancer cancer Chih-Chiang Hung Chiun-Sheng Huang Christoph Cramer von Laue Cristina Saura Elgene Lim Emily Barrett Eriko Tokunaga François-Clément Bidard Giuseppe Curigliano Joohyuk Sohn Jorge Luis Martinez Rodriguez Joyce O'Shaughnessy Kamnesh R. Pradhan Komal L. Jhaveri Lillian M. Smyth Lisa A. Carey Manuel Ruiz Borrego María de la Luz García Tinoco Monica Lis Casalnuovo Nadia Harbeck OncoDaily Oncology Patrick Neven Philippe Aftimos Qingyuan Zhang Rikiya Nakamura Shanshan Cao Sung-Bae Kim Xuejing Aimee Wang
Special Coverage
Voices
Sep 7, 2025, 15:52
Muhammad Umair Mushtaq: From Love to Global Good in Hematology
Science
Sep 7, 2025, 15:52
Paolo Tarantino: ctDNA Analysis of SONIA Has Been Published in Nature Medicine
Insight
Sep 7, 2025, 15:47
Highlights from SOHO 2025 Annual Meeting
Voices
Sep 7, 2025, 15:42
Brunilda Profka Haxhiu: Radiotherapy Must be Seen as a Right, not a Privilege
Voices
Sep 7, 2025, 15:41
Lisa Lacasse: Highlighting the Potential of Multi-Cancer Early Detection Tests
Blog Posts
Sep 7, 2025, 15:37
Ana Barac: New Era of Myocardial Strain at ASE 2025
Voices
Sep 7, 2025, 15:32
Sumanta Pal: Contribution of IO in TKI/IO Combinations For Non-Clear Cell Kidney Cancer
Voices
Sep 7, 2025, 15:24
Katie Coleman: “What Do Patients Want” is a Moving Target
Insight
Sep 7, 2025, 15:17
Udhayvir Grewal: Palliative Care and End-of-Life Care in Esophageal Cancer
Voices
Sep 7, 2025, 14:57
Zeynep Ozay: Learning and Growing at Huntsman Cancer Institute
Insight
Sep 7, 2025, 14:57
Gerry Hanna Spotlights Editorial on Reframing Radiotherapy in Radiation Oncology
Voices
Sep 7, 2025, 14:41
Roberto Borea: My Very First WCLC 2025 as an IASLC Academy Member